| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-08 |
详情>>
内部人交易：
ROSENMAN HERM等共交易11笔
|
| 2021-03-06 |
复牌提示：
2021-03-05 19:50:05 停牌，复牌日期 2021-03-09 00:00:01
|
| 2021-01-29 |
股东大会：
将于2021-02-26召开股东大会
会议内容 ▼▲
- 1.to authorize the Company Board to take all necessary action to carry the Scheme into effect.
2.to amend the Company Articles to ensure that any Company Shares issued after the Scheme Record Time will be subject to the Scheme or otherwise transferred to Bidco, so that no other person will hold Company Shares following the Effective Date.
|
| 2021-01-29 |
详情>>
股本变动：
变动后总股本2557.78万股
|
| 2020-11-03 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-0.61美元,归母净利润-1586.1万美元,同比去年增长-8292.06%
|
| 2020-11-03 |
财报披露：
美东时间 2020-11-03 盘前发布财报
|
| 2020-08-04 |
详情>>
业绩披露：
2020年中报每股收益-0.6美元,归母净利润-1571.2万美元,同比去年增长-1634.22%
|
| 2020-06-01 |
股东大会：
将于2020-06-11召开股东大会
会议内容 ▼▲
- 1.To elect Patrick J. Balthrop, Sr. as a class I director for a term to expire at the 2023 annual general meeting of shareholders.
2.To elect Patricia Randall as a class I director for a term to expire at the 2023 annual general meeting of shareholders.
3.To elect Herm Rosenman as a class I director for a term to expire at the 2023 annual general meeting of shareholders.
4.To ratify the Audit Committee’s appointment of Ernst & Young LLP, the U.S. member firm of Ernst & Young Global Limited, as our U.S. independent registered public accounting firm for the fiscal year ending December 31, 2020.
5.To re-appoint the U.K. member firm of Ernst & Young Global Limited, Ernst & Young LLP, as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next annual general meeting of shareholders at which the U.K. statutory accounts and reports are presented.
6.To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the fiscal year ending December 31, 2020.
7.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2019.
8.To receive and approve our U.K. statutory annual directors’ remuneration report for the year ended December 31, 2019, which is set forth as Part I of Annex A to this Proxy Statement.
9.To approve, on a non-binding, advisory basis, the compensation paid to the named executive officers of the Company as disclosed in the section of this Proxy Statement titled “Executive Compensation”.
10.To approve our Directors’ Remuneration Policy, which, if approved, will take effect upon the conclusion of the Meeting, the full text of which is set forth as Part II of Annex A to this Proxy Statement.
11.That, in substitution for all existing authorities, the Directors be, and are, hereby generally and unconditionally authorised pursuant to section 551 of the U.K. Companies Act 2006 to exercise all the powers of the Company to:
(a)allot shares in the Company and to grant rights to subscribe for or to convert any security into such shares up to an aggregate maximum nominal amount of ￡57,989, representing 33.3% of the nominal issued share capital of the Company;
(b)allot further equity securities (within the meaning of section 560(1) of the U.K. Companies Act 2006) up to an aggregate maximum nominal amount of ￡57,989, representing 33.3% of the nominal issued share capital of the Company, in connection with a right issue in favour of shareholders where such authority to expire at the end of the next annual general meeting of the shareholders following the passing of this resolution or, if earlier, at the close of business on 11 September 2021 (unless previously revoked or varied by the Company in general meeting) but, in each case, prior to its expiry, revocation or variation the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires, or is otherwise revoked or varied and the Directors may allot equity securities (and sell treasury shares) under any such offer or agreement as if this authority had not expired or been revoked or varied.
12. That, subject to the passing of Resolution 11 and in substitution for all existing authorities, the Directors be authorised to allot equity securities (as defined in section 560 of the U.K. Companies Act 2006) for cash under the authority given by Resolution 11 and/ or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the U.K. Companies Act 2006 did not apply to any such allotment or sale, such authority to be limited:
(a) to the allotment of equity securities and/or sale of treasury shares for cash in connection with an offer of, or an invitation to apply for, equity securities (but in the case of an allotment pursuant to the authority granted by paragraph (b) of Resolution 11, by way of rights issue only):
(i)in favour of ordinary shareholders where the equity securities are proportionate (as nearly as practicable) to the respective number of ordinary shares held by such holders;
(ii)to holders of other equity securities, as required by the rights of those securities or, subject to such rights, as the Directors otherwise consider necessary, and so that the Directors may impose any limits or restrictions or make any other arrangements as the Directors may deem necessary or appropriate in relation to treasury shares, fractional entitlements, record dates, or legal or practical problems arising in, or pursuant to, the laws of any territory or the requirements of any regulatory body or stock exchange in any territory, or any other matter;
(b)to the allotment of equity securities or sale of treasury shares (otherwise than under paragraph (a) above) up to an aggregate maximum nominal amount of ￡8,698, representing 5% of the nominal issued share capital of the Company, such authority to expire at the end of the next annual general meeting of the shareholders following the passing of this resolution or, if earlier, at the close of business on 11 September 2021 (unless previously revoked or varied by the Company in general meeting) but, in each case, prior to its expiry, revocation or variation the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires, or is otherwise revoked or varied and the Directors may allot equity securities (and sell treasury shares) under any such offer or agreement as if this authority had not expired or been revoked or varied.
13.That, subject to the passing of Resolution 11 and in substitution for all existing authorities, the Directors be authorised in addition to any authority granted under Resolution 12 to allot equity securities (as defined in section 560 of the U.K. Companies Act 2006) for cash under the authority given by Resolution 11 and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the U.K. Companies Act 2006 did not apply to any such allotment or sale, such authority to be:
(a)limited to the allotment of equity securities or sale of treasury shares up to an aggregate maximum nominal amount of ￡8,698 representing 5% of the nominal issued share capital of the Company;
(b)used only for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) a transaction which the Board of the Company determines to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group, such authority to expire at the end of the next annual general meeting of the shareholders following the passing of this resolution or, if earlier, at the close of business on 11 September 2021 (unless previously revoked or varied by the Company in general meeting) but, in each case, prior to its expiry, revocation or variation the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires, or is otherwise revoked or varied and the Directors may allot equity securities (and sell treasury shares) under any such offer or agreement as if this authority had not expired or been revoked or varied.
|
| 2020-06-01 |
股东大会：
将于2020-06-24召开股东大会
会议内容 ▼▲
- 1.To elect Patrick J. Balthrop, Sr. as a class I director for a term to expire at the 2023 annual general meeting of shareholders.
2.To elect Patricia Randall as a class I director for a term to expire at the 2023 annual general meeting of shareholders.
3.To elect Herm Rosenman as a class I director for a term to expire at the 2023 annual general meeting of shareholders.
4.To ratify the Audit Committee’s appointment of Ernst & Young LLP, the U.S. member firm of Ernst & Young Global Limited, as our U.S. independent registered public accounting firm for the fiscal year ending December 31, 2020.
5.To re-appoint the U.K. member firm of Ernst & Young Global Limited, Ernst & Young LLP, as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next annual general meeting of shareholders at which the U.K. statutory accounts and reports are presented.
6.To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the fiscal year ending December 31, 2020.
7.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2019.
8.To receive and approve our U.K. statutory annual directors’ remuneration report for the year ended December 31, 2019, which is set forth as Part I of Annex A to this Proxy Statement.
9.To approve, on a non-binding, advisory basis, the compensation paid to the named executive officers of the Company as disclosed in the section of this Proxy Statement titled “Executive Compensation”.
10.To approve our Directors’ Remuneration Policy, which, if approved, will take effect upon the conclusion of the Meeting, the full text of which is set forth as Part II of Annex A to this Proxy Statement.
11.That, in substitution for all existing authorities, the Directors be, and are, hereby generally and unconditionally authorised pursuant to section 551 of the U.K. Companies Act 2006 to exercise all the powers of the Company to:
(a)allot shares in the Company and to grant rights to subscribe for or to convert any security into such shares up to an aggregate maximum nominal amount of ￡57,989, representing 33.3% of the nominal issued share capital of the Company;
(b)allot further equity securities (within the meaning of section 560(1) of the U.K. Companies Act 2006) up to an aggregate maximum nominal amount of ￡57,989, representing 33.3% of the nominal issued share capital of the Company, in connection with a right issue in favour of shareholders where such authority to expire at the end of the next annual general meeting of the shareholders following the passing of this resolution or, if earlier, at the close of business on 11 September 2021 (unless previously revoked or varied by the Company in general meeting) but, in each case, prior to its expiry, revocation or variation the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires, or is otherwise revoked or varied and the Directors may allot equity securities (and sell treasury shares) under any such offer or agreement as if this authority had not expired or been revoked or varied.
12. That, subject to the passing of Resolution 11 and in substitution for all existing authorities, the Directors be authorised to allot equity securities (as defined in section 560 of the U.K. Companies Act 2006) for cash under the authority given by Resolution 11 and/ or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the U.K. Companies Act 2006 did not apply to any such allotment or sale, such authority to be limited:
(a) to the allotment of equity securities and/or sale of treasury shares for cash in connection with an offer of, or an invitation to apply for, equity securities (but in the case of an allotment pursuant to the authority granted by paragraph (b) of Resolution 11, by way of rights issue only):
(i)in favour of ordinary shareholders where the equity securities are proportionate (as nearly as practicable) to the respective number of ordinary shares held by such holders;
(ii)to holders of other equity securities, as required by the rights of those securities or, subject to such rights, as the Directors otherwise consider necessary, and so that the Directors may impose any limits or restrictions or make any other arrangements as the Directors may deem necessary or appropriate in relation to treasury shares, fractional entitlements, record dates, or legal or practical problems arising in, or pursuant to, the laws of any territory or the requirements of any regulatory body or stock exchange in any territory, or any other matter;
(b)to the allotment of equity securities or sale of treasury shares (otherwise than under paragraph (a) above) up to an aggregate maximum nominal amount of ￡8,698, representing 5% of the nominal issued share capital of the Company, such authority to expire at the end of the next annual general meeting of the shareholders following the passing of this resolution or, if earlier, at the close of business on 11 September 2021 (unless previously revoked or varied by the Company in general meeting) but, in each case, prior to its expiry, revocation or variation the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires, or is otherwise revoked or varied and the Directors may allot equity securities (and sell treasury shares) under any such offer or agreement as if this authority had not expired or been revoked or varied.
13.That, subject to the passing of Resolution 11 and in substitution for all existing authorities, the Directors be authorised in addition to any authority granted under Resolution 12 to allot equity securities (as defined in section 560 of the U.K. Companies Act 2006) for cash under the authority given by Resolution 11 and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the U.K. Companies Act 2006 did not apply to any such allotment or sale, such authority to be:
(a)limited to the allotment of equity securities or sale of treasury shares up to an aggregate maximum nominal amount of ￡8,698 representing 5% of the nominal issued share capital of the Company;
(b)used only for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) a transaction which the Board of the Company determines to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group, such authority to expire at the end of the next annual general meeting of the shareholders following the passing of this resolution or, if earlier, at the close of business on 11 September 2021 (unless previously revoked or varied by the Company in general meeting) but, in each case, prior to its expiry, revocation or variation the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires, or is otherwise revoked or varied and the Directors may allot equity securities (and sell treasury shares) under any such offer or agreement as if this authority had not expired or been revoked or varied.
|
| 2020-05-05 |
详情>>
业绩披露：
2020年一季报每股收益-0.23美元,归母净利润-602.7万美元,同比去年增长-302.87%
|
| 2020-03-06 |
详情>>
业绩披露：
2019年年报每股收益-0.07美元,归母净利润-180.9万美元,同比去年增长-101.5%
|
| 2019-11-05 |
详情>>
业绩披露：
2019年三季报(累计)每股收益-0.01美元,归母净利润-18.9万美元,同比去年增长99.07%
|
| 2019-08-06 |
详情>>
业绩披露：
2018年中报每股收益-0.65美元,归母净利润-1679.7万美元,同比去年增长32.37%
|
| 2019-08-06 |
详情>>
业绩披露：
2019年中报每股收益-0.03美元,归母净利润-90.6万美元,同比去年增长94.61%
|
| 2019-05-09 |
详情>>
业绩披露：
2019年一季报每股收益-0.06美元,归母净利润-149.6万美元,同比去年增长85.51%
|
| 2019-04-30 |
股东大会：
将于2019-06-18召开股东大会
会议内容 ▼▲
- 1.To elect Richard A. Sandberg as a class III director for a term to expire at the 2022 annual general meeting of shareholders;
2.To elect Andrew Scott Walton as a class III director for a term to expire at the 2022 annual general meeting of shareholders;
3.To elect Peter Wrighton-Smith as a class III director for a term to expire at the 2022 annual general meeting of shareholders;
4.To ratify the Audit Committee’s appointment of Ernst & Young LLP, the U.S. member firm of Ernst & Young Global Limited, as our U.S. independent registered public accounting firm for the fiscal year ending December 31, 2019;
5.To re-appoint the U.K. member firm of Ernst & Young Global Limited, Ernst & Young LLP, as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next annual general meeting of shareholders at which the U.K. statutory accounts and reports are presented;
6.To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the fiscal year ending December 31, 2019;
7.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2018;
8.To receive and approve our U.K. statutory annual directors’ remuneration report for the year ended December 31, 2018, which is set forth as Annex A to this proxy statement;
9.To approve, on a non-binding, advisory basis, the compensation paid to the named executive officers of the Company as disclosed in the section of this proxy statement titled “Executive Compensation”;
10.To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve the compensation paid to the named executive officers of the Company;
11.To (i) approve the terms of the proposed purchase agreement or agreements providing for the purchase by the Company of our ordinary shares in the aggregate amount of up to $100,000,000 from one or more financial intermediaries and (ii) authorize the Company to make off-market purchases of its ordinary shares pursuant to such agreement or agreements, the full text of which can be found in “Annex B” to this proxy statement. The authority conferred by “Proposal 11” will, unless varied, revoked or renewed by the shareholders or discontinued by the Board of Directors prior to such time, expire five years after the date of the passing of this resolution;
12.To resolve that our Board of Directors be generally and unconditionally authorized to exercise all powers of the Company to allot ordinary shares of the Company or grant rights to subscribe for, or to convert any security into, ordinary shares up to an aggregate nominal amount of ￡59,503 representing 33% of the nominal value of the issued share capital of the Company as of April 22, 2019;
13.To approve the general disapplication of pre-emption rights with respect to the allotment of ordinary shares and rights over ordinary shares referred to in Proposal 12, the full text of which can be found in “Proposal 13” of this proxy statement.
|
| 2019-03-28 |
详情>>
业绩披露：
2017年年报每股收益-1.38美元,归母净利润-3288.5万美元,同比去年增长-47.14%
|
| 2019-03-28 |
详情>>
业绩披露：
2018年年报每股收益4.65美元,归母净利润1.21亿美元,同比去年增长467.28%
|
| 2018-11-09 |
详情>>
业绩披露：
2018年三季报(累计)每股收益-0.78美元,归母净利润-2028.1万美元,同比去年增长51.35%
|
| 2018-04-27 |
股东大会：
将于2018-06-19召开股东大会
会议内容 ▼▲
- 1.To elect Ronald A. Andrews, Jr. as a class II director for a term to expire at the 2021 annual general meeting of shareholders;
2.To elect Mark Klausner as a class II director for a term to expire at the 2021 annual general meeting of shareholders;
3.To elect James R. Tobin as a class II director for a term to expire at the 2021 annual general meeting of shareholders;
4.To ratify the Audit Committee’s appointment of Ernst & Young LLP, the U.S. member firm of Ernst & Young Global Limited, as our U.S. independent registered public accounting firm for the fiscal year ending December 31, 2018;
5.To re-appoint the U.K. member firm of Ernst & Young Global Limited, Ernst & Young LLP, as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. statutory accounts and reports are presented;
6.To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the fiscal year ending December 31, 2018;
7.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2017;
8.To receive and approve our U.K. statutory annual directors’ remuneration report for the year ended December 31, 2017, which is set forth as Annex A to this proxy statement.
|
| 2017-04-25 |
股东大会：
将于2017-06-06召开股东大会
会议内容 ▼▲
- 1.To elect Patrick J. Balthrop, Sr. as a class I director for a term to expire at the 2020 annual general meeting of shareholders;
2.To elect Patricia Randall as a class I director for a term to expire at the 2020 annual general meeting of shareholders;
3.To elect Herm Rosenman as a class I director for a term to expire at the 2020 annual general meeting of shareholders;
4.To ratify the Audit Committee’s appointment of Ernst & Young LLP as our U.K. statutory auditor and U.S. independent registered public accounting firm for the fiscal year ending December 31, 2017;
5.To re-appoint Ernst & Young LLP as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. statutory accounts and reports are presented;
6.To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the fiscal year ending December 31, 2017;
7.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2016;
8.To receive and approve our U.K. statutory annual directors’ remuneration report for the year ended December 31, 2016, which is set forth as Annex A to this proxy statement;
9.To approve our Directors’ Remuneration Policy, which, if approved, will take effect upon the conclusion of the Meeting, the full text of which is set forth as Part II of Annex A to this proxy statement;
10.To approve the amendment of the 2013 Share Incentive Plan, the full text of which is set forth in Annex B to this proxy statement.
|
| 2016-05-02 |
股东大会：
将于2016-06-28召开股东大会
会议内容 ▼▲
- 1. To elect Patrick J. Balthrop, Sr. as a class I director for a term to expire at the 2017 annual general meeting of shareholders;
2. To elect Ronald A. Andrews, Jr. as a class II director for a term to expire at the 2018 annual general meeting of shareholders;
3. To elect Richard A. Sandberg as a class III director for a term to expire at the 2019 annual general meeting of shareholders;
4. To elect A. Scott Walton as a class III director for a term to expire at the 2019 annual general meeting of shareholders;
5. To elect Peter Wrighton-Smith Ph.D., as a class III director for a term to expire at the 2019 annual general meeting of shareholders;
6. To ratify the Audit Committee’s appointment of Ernst & Young LLP as our U.K. statutory auditor and U.S. independent registered public accounting firm for the fiscal year ending December 31, 2016;
7. To re-appoint Ernst & Young LLP as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. statutory accounts and reports are presented;
8. To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the fiscal year ending December 31, 2016;
9. To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2015;
10. To receive and approve our U.K. statutory annual directors’ remuneration report for the year ended December 31, 2015, which is set forth as Annex A to this proxy statement.
|
| 2015-04-28 |
股东大会：
将于2015-06-09召开股东大会
会议内容 ▼▲
- 1.To elect James R. Tobin as a class II director for a term to expire at the 2018 annual general meeting of shareholders;
2.To elect Stephen L. Spotts as a class II director for a term to expire at the 2018 annual general meeting of shareholders;
3.To ratify the Audit Committee’s appointment of Ernst & Young LLP as our U.K. statutory auditor and U.S. independent registered public accounting firm for the fiscal year ending December 31, 2015;
4.To re-appoint Ernst & Young LLP as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. statutory accounts and reports are presented;
5.To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the fiscal year ending December 31, 2015;
6.To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2014;
7.To receive and approve our U.K. statutory annual directors’ remuneration report for the year ended December 31, 2014, which is set forth as Annex A to this proxy statement.
|
| 2014-04-29 |
股东大会：
将于2014-06-12召开股东大会
会议内容 ▼▲
- 1. Election of Herm Rosenman as a class I director to serve for a term to expire at the 2017 annual general meeting of shareholders and until his successor has been elected and qualified.
2. Election of Patricia Randall as a class I director to serve for a term to expire at the 2017 annual general meeting of shareholders and until her successor has been elected and qualified.
3. To ratify the Audit Committee’s appointment of Ernst & Young LLP as our U.K. statutory auditor and U.S. independent registered public accounting firm for the fiscal year ended December 31, 2013.
4. To re-appoint Ernst & Young LLP as our U.K. statutory auditors under the U.K. Companies Act 2006, to hold office until the conclusion of the next general meeting of shareholders at which the U.K. statutory accounts and reports are presented.
5. To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration.
6. To receive the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2013.
7. To receive our U.K. statutory directors’ remuneration report for the year ended December 31, 2013, which is set forth as Annex A to this proxy statement, and approve the annual report on remuneration, which is set forth as Part I of Annex A.
8. To receive and approve our directors’ remuneration policy, which will take effect immediately upon the conclusion of the Meeting, the full text of which is set forth as Part II of Annex A to this proxy statement.
9. Authorization for the Board of Directors to allot ordinary shares and rights over ordinary shares up to a maximum aggregate nominal amount of ￡100,000.
10. Authorization for the disapplication of U.K. statutory rights of preemption with respect to the allotment of ordinary shares and rights over ordinary shares referred to in Resolution 9.
11. To amend Articles 13.1, 72 and 73 of our Articles of Association to change the quorum requirement for general meetings.
12. To amend Article 220 of our Articles of Association to require notice of board meetings to be furnished to all Directors.
|